SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-042319
Filing Date
2017-06-29
Accepted
2017-06-29 16:40:52
Documents
2
Period of Report
2017-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1524
2 POA DOCUMENT poa.txt EX-24.3_733676 3662
  Complete submission text file 0001209191-17-042319.txt   6571
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
JEFFS ROGER (Reporting) CIK: 0001231615 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30171 | Film No.: 17938811